CV Sciences, Inc. (OTCQB: CVSI) announced this morning that the company’s second quarter 2018 revenue is expected to have reached $12.3 million, which is up 203% compared to their second quarter last year. The company owns the well-known hemp derived CBD product brand +CBD oil.
CV Sciences owns their own pharmaceutical drug division that works specifically on the research and development of commercial CBD Products. Their subsidiary +CBD Oil focused on the manufacturing, marketing, and distribution of Cannabidiol based products such as soft gel capsules, powdered capsules, sublingual tinctures, topical and sprays.
In the announcement, CV Sciences indicated that the company has increased their retail store count to 1,968 organic health food stores as of the end of June 2018. By allowing customers to purchase online, as well as, through retail outlets across the country the company has been able to significantly increase its visibility with consumers.
CV Sciences, Inc. currently has a market cap of $234.82m and is trading at 2.769 per share.
You may be interested
MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5MEditor - October 19, 2018
MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF) announced this week that the company has agreed to sell three seperate cannabis retail locations to Treehouse Real Estate Investment…
CashCropToday | 411/420 | Cannapreneur Bo Money Discusses Events For Social Equity Plan (Part 3)Jaelynn Offerman - October 18, 2018
Host Joya Italiano continues her discussion with cannapreneur and social equity advocate, Bo Money. Bo reveals upcoming plans stored in place and discusses the reasoning behind the…
Public Companies iAnthus & MPX Bioceutical Announce Official MergerEditor - October 18, 2018
iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF), and MPX Bioceutical Corporation (CSE: MPX) (OTC: MPXEF) have announced this morning that the companies signed an agreement to merge…